News

The financing will be used to apply Expression Pathology’s patented Liquid Tissue proteomics technology in developing personalized medicine clinical assays that relate measurement of protein biomarkers of drug

The Phase I dose-escalation trial is planned to enroll 45 healthy volunteers and is designed to expand the human safety database. The company also reported the results of

This contract is with an existing client, and has a minimum value of $579,000. The contract brings the total value of US pharmaceutical trial contracts secured over the

RadNet, a provider of diagnostic imaging services, has completed the acquisition of the assets of Inter-County Imaging of Yonkers, New York from Medical Resources. It has also signed

At Mpex Mr Wiggins will be focusing on commercial planning and business development activities related to the company’s lead product, MP-376. MP-376 is an inhaled antibiotic which is

Dr Bobotas has been president and managing partner of DeMelleBioPharma, since 2008. Dr Bobotas was employed at Reliant Pharmaceuticals, a wholly owned subsidiary of GlaxoSmithKline, for eight years

Mr Monast will report to Gregory Weishar, the company’s president and CEO. Mr Monast will be responsible for PharMerica’s pharmacy, clinical and billing operations, customer services and account

Last week, an EPA administrator told GlobalChem attendees that EPA may soon decide to regulate nanomaterials. According to the official, this rulemaking would be in reaction to a

Allos Therapeutics, a biopharmaceutical company, has reported new data demonstrating the anticancer activity of its investigational drug, pralatrexate, in colon, ovarian, lung, prostate, and head and neck cancer